ArticleRenal failure2025

Fedratinib in chronic kidney disease: antifibrotic potential and renal safety signals from integrated network toxicology and pharmacovigilance.

Rubin Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.